✦ LIBER ✦

Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: Results from the LIPID study

✍ Scribed by Andrew M. Tonkin; Simon Eckermann; Harvey White; Denis Friedlander; Paul Glasziou; Paul Magnus; Adrienne Kirby; Sarah Mulray; Mary Denton; Michele Sallaberger; David Hunt; John Simes

Book ID: 116190341
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 124 KB
Volume: 151
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2005.07.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of High-Dose Atorvastatin in Pat

Effects of High-Dose Atorvastatin in Patients ≥65 Years of Age With Acute Coronary Syndrome (from the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering [MIRACL] Study)

✍ Anders G. Olsson; Gregory G. Schwartz; Michael Szarek; Don Luo; Michael J. Jamie 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Comparison of Efficacy and Safety of Ato

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)

✍ Matti J. Tikkanen; Ingar Holme; Nilo B. Cater; Michael Szarek; Ole Faergeman; Jo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Relationship of Oxidized Phospholipids a

Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes: Results From the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) Trial

✍ Alexander E. Fraley; Gregory G. Schwartz; Anders G. Olsson; Scott Kinlay; Michae 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 561 KB